Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Hoshiya S et al. |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. |
2000 |
J. Gastroenterol. |
pmid:10632534
|
Fujioka T |
Clarithromycin resistance in Helicobacter pylori: implications for therapy. |
2000 |
J. Gastroenterol. |
pmid:10632546
|
Bardhan KD et al. |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632646
|
Vcev A et al. |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632647
|
Cammarota G et al. |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632648
|
Gasbarrini A et al. |
Efficacy of a multistep strategy for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632649
|
Chan FK et al. |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632651
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Keiser P et al. |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. |
1999 |
Int J STD AIDS |
pmid:10639059
|
Miyanohara T et al. |
Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. |
2000 |
Laryngoscope |
pmid:10646728
|
Graham DY et al. |
Furazolidone combination therapies for Helicobacter pylori infection in the United States. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651662
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Fock KM et al. |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651664
|
Chiba N and Marshall CP |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. |
2000 |
Can. J. Gastroenterol. |
pmid:10655024
|
Alarcón T et al. |
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. |
2000 |
J. Clin. Microbiol. |
pmid:10655418
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Yatsunami J et al. |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. |
1999 |
Cancer Lett. |
pmid:10660084
|